Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Recommendation of "Buy" from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Top Pictet Fund Manager Sees Biotech Stocks Joining AI-Euphoria bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
VANCOUVER, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the Stifel 2024
TimesSquare Capital Management LLC Has $20.17 Million Stock Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Polar Capital Holdings Plc reduced its stake in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 0.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,003,747 shares of the biopharmaceutical company’s stock after selling 18,324 shares during […]